BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Business

  Tesaro, Inc. And Merck & Co. To Collaborate On A Combination Study Of Niraparib And KEYTRUDA (Pembrolizumab)

  June 1, 2015

   · 

  12 min read
• Drug Development

  ASCO15: AstraZeneca PLC Presents Positive Data On AZD9291 In First-Line EGFR Mutated Lung Cancer At ASCO 2015

  June 1, 2015

   · 

  9 min read
• Drug Development

  Apricus Biosciences Enrolls First Patients In Phase IIb Clinical Trial For Fispemifene In Men With Symptomatic Secondary Hypogonadism

  June 1, 2015

   · 

  5 min read
• Business

  Inform Genomics Selects ICON As Contract Research Organization (CRO) For Pivotal Multicenter Study Of HSCT/Mucositis Product Candidate

  June 1, 2015

   · 

  3 min read
• Drug Development

  ASCO15: ImmunoGen’s Mirvetuximab Soravtansine (IMGN853) Demonstrates Notable Single Agent Activity For Patients With Platinum-Resistant Ovarian Cancer

  June 1, 2015

   · 

  6 min read
• Drug Development

  ASCO15: Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival In Phase 3 Trial For Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy

  June 1, 2015

   · 

  13 min read
• Drug Development

  ASCO15: CTI BioPharma Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015

  June 1, 2015

   · 

  13 min read
• Drug Development

  OncoGenex Pharmaceuticals Inc. Announces Data From The Phase 3 SYNERGY Trial Showing A Survival Benefit With Custirsen In Patients With Poor Prognosis

  June 1, 2015

   · 

  8 min read
• Drug Development

  Pharmacyclics Release: Ibrutinib (IMBRUVICA) Phase Ib/II Data Show Promise In Patients With Chronic Graft-Versus-Host-Disease

  June 1, 2015

   · 

  12 min read
• Drug Development

  Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory Multiple Myeloma

  June 1, 2015

   · 

  17 min read